XPEL, Inc. (NASDAQ:XPEL – Get Free Report)’s share price was down 5.9% during trading on Tuesday following insider selling activity. The stock traded as low as $43.76 and last traded at $43.76. Approximately 65,417 shares were traded during trading, a decline of 67% from the average daily volume of 197,225 shares. The stock had previously closed at $46.52.
Specifically, CEO Ryan Pape sold 20,000 shares of XPEL stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $46.34, for a total value of $926,800.00. Following the transaction, the chief executive officer now owns 1,085,607 shares in the company, valued at $50,307,028.38. The trade was a 1.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Wall Street Analysts Forecast Growth
XPEL has been the topic of a number of recent analyst reports. B. Riley upgraded shares of XPEL from a “neutral” rating to a “buy” rating and raised their price target for the company from $37.00 to $58.00 in a report on Friday, August 9th. Craig Hallum raised shares of XPEL from a “hold” rating to a “buy” rating in a report on Thursday, August 8th.
XPEL Stock Performance
The firm has a market cap of $1.20 billion, a price-to-earnings ratio of 24.83 and a beta of 1.85. The stock’s 50 day simple moving average is $42.58 and its 200-day simple moving average is $40.02.
XPEL (NASDAQ:XPEL – Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.01. XPEL had a return on equity of 24.68% and a net margin of 11.61%. The business had revenue of $112.85 million for the quarter, compared to the consensus estimate of $114.59 million. During the same quarter in the previous year, the business earned $0.56 EPS. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. On average, analysts expect that XPEL, Inc. will post 1.73 EPS for the current fiscal year.
Institutional Trading of XPEL
Institutional investors and hedge funds have recently bought and sold shares of the business. Louisiana State Employees Retirement System raised its holdings in shares of XPEL by 2.8% during the third quarter. Louisiana State Employees Retirement System now owns 11,000 shares of the company’s stock worth $477,000 after purchasing an additional 300 shares during the last quarter. Mendota Financial Group LLC grew its position in XPEL by 11.4% during the 2nd quarter. Mendota Financial Group LLC now owns 3,606 shares of the company’s stock worth $128,000 after purchasing an additional 370 shares during the period. Wealth Enhancement Advisory Services LLC raised its stake in shares of XPEL by 0.3% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 157,296 shares of the company’s stock valued at $6,822,000 after buying an additional 432 shares during the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of XPEL by 3.5% in the 3rd quarter. State of Alaska Department of Revenue now owns 12,934 shares of the company’s stock valued at $560,000 after buying an additional 441 shares during the period. Finally, GAMMA Investing LLC boosted its position in XPEL by 190.4% in the 3rd quarter. GAMMA Investing LLC now owns 784 shares of the company’s stock worth $34,000 after purchasing an additional 514 shares in the last quarter. 75.08% of the stock is currently owned by institutional investors and hedge funds.
About XPEL
XPEL, Inc sells, distributes, and installs protective films and coatings worldwide. The company offers automotive surface and paint protection film, headlight protection, and automotive and architectural window films, as well as proprietary DAP software. It also provides pre-cut film products, merchandise and apparel, ceramic coatings, and tools and accessories.
Recommended Stories
- Five stocks we like better than XPEL
- What is a buyback in stocks? A comprehensive guide for investors
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Investing In Preferred Stock vs. Common Stock
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Invest in the FAANG Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for XPEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XPEL and related companies with MarketBeat.com's FREE daily email newsletter.